EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Amani Elshaer, David M H Chascsa iD, Blanca C Lizaola-Mayo

Life · 03.07.2024 · 14 (7) · 844

DOI: 10.3390/life14070844 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 03.07.2024. Verfasst von Amani Elshaer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ 85054, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a liver disorder characterized by steatosis with underlying metabolic risk factors. The prevalence of MASLD continues to rise, leading to increased patient risk of various complications. Recent research has been focused on new therapeutic strategies to reduce the incidence of MASLD and provide effective treatment plans to prevent further irreversible liver damage. The treatment approach is multifactorial, with a primary focus on weight loss and management of underlying comorbidities through lifestyle modifications, pharmacotherapy, or surgical options. Ongoing research is exploring new pharmacological therapies that could enhance the treatment of MASLD.

Schlagwörter

Stichwörter der Autor:innen

bariatric surgerycirrhosisfibrosislifestyle modificationmetabolic-associated steatotic liver diseaseobesitypharmacotherapyweight loss

Autor:innen und Institutionen

  • Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ 85054, USA.
  • Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ 85054, USA.
  • Transplant Center, Department of Medicine, Mayo Clinic, Scottsdale, AZ 85054, USA.

ORCID-Profile: David M H Chascsa

Zitieren

APA

Elshaer, A., Chascsa, D. M. H., & Lizaola-Mayo, B. C. (2024). Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Life, 14(7), 844. https://doi.org/10.3390/life14070844

Vancouver

Elshaer A, Chascsa DMH, Lizaola-Mayo BC. Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Life. 2024;14(7):844. doi:10.3390/life14070844

BibTeX
@article{Elshaer2024,
  author = {Elshaer, Amani and Chascsa, David M H and Lizaola-Mayo, Blanca C},
  title = {Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {844},
  doi = {10.3390/life14070844}
}
Kostenlos starten →